LCTX Key Metrics | Stock Alarm Pro

Sign In Create Free Alerts

Lineage Cell Therapeutics, Inc.LCTXNYSE

Loading

Overview Intelligence Charts News Fundamentals Key Metrics Earnings Growth Financials Insiders

Key Metrics

As of 2025• vs 2024

Core Metrics

Market Cap

$384.29M+282.0%

-142.61%-500.7%

Interest Coverage

Per Share

Revenue/Share

$0.06+33.3%

Net Income/Share

$-0.28-197.0%

Operating CF/Share

$-0.08+28.7%

Free CF/Share

$-0.08+28.5%

Cash/Share

$0.24+1.5%

Book Value/Share

$0.19-51.0%

Tangible Book/Share

$0.00-95.7%

Equity/Share

$0.19-50.6%

Interest Debt/Share

$0.01-16.3%

Valuation

Market Cap

$384.29M+282.0%

Enterprise Value

$345.92M+503.5%

P/OCF Ratio

-20.31-366.3%

P/FCF Ratio

-19.77-364.9%

P/TB Ratio

8.63+572.1%

EV/EBITDA

-16.41-497.4%

Profitability

-142.61%-500.7%

Return on Tangible Assets

Capital Allocation

CapEx/OCF

-2.76%-12.8%

CapEx/Revenue

3.59%-39.7%

CapEx/Depreciation

0.75-19.5%

SBC/Revenue

32.65%-38.9%

Balance Sheet

Net Debt/EBITDA

1.82-12.2%

Interest Coverage

Efficiency

Days Sales Outstanding

39 days+59.8%

Days Payables Outstanding

1011 days-21.2%

Days Inventory

0 days

Receivables Turnover

9.32x-37.4%

Payables Turnover

0.36x+26.9%

Inventory Turnover

0.00x

Special Valuations

Graham Number

--

Graham Net-Net

$-0.05-188.5%

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance